Advances in the treatment of neuromyelitis optic spectrum disorder
Neuromyelitis optic spectrum disorder (NMOSD) is a rare autoimmune disease characterized by recurrent episodes and severe debilitation. It primarily involves the central nervous system and is associated with the presence of aquaporin-4 antibodies. Effective management of NMOSD necessitates long-term...
Saved in:
| Main Authors: | Xiaolin Yang, Shaoru Zhang, Jinzhou Feng, Xinyue Qin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864251328276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective
by: Lidong Liu, et al.
Published: (2025-05-01) -
Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune Disorders
by: Zuo S, et al.
Published: (2025-04-01) -
Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab
by: Jing Zhou, et al.
Published: (2025-04-01) -
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)
by: T. O. Simaniv, et al.
Published: (2023-08-01) -
Possibilities of therapy for neuromyelitis optica spectrum disorders
by: E. S. Novikova
Published: (2022-01-01)